GenetikaPlus Ltd. – Trademark Portfolio

Entity Type: 99

GenetikaPlus Ltd. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 6 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include STEMIFAI and NEUROKAIRE. The owner is based in Kearny, NJ.

78 John Miller Way, Unit #420

Kearny, NJ 07032

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

GenetikaPlus Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (6 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does GenetikaPlus Ltd. have?

GenetikaPlus Ltd. has 6 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 abandoned.

What trademark classes does GenetikaPlus Ltd. file in?

GenetikaPlus Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 42 (Computer & Scientific). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What are GenetikaPlus Ltd.'s most well-known trademarks?

GenetikaPlus Ltd.'s registered trademark portfolio includes well-known marks such as STEMIFAI and NEUROKAIRE. These are among 4 currently registered trademarks in the portfolio.

What is GenetikaPlus Ltd.'s trademark registration success rate?

GenetikaPlus Ltd. has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.